Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05782179

Recruitment Status : Active, not recruiting

First Posted : March 23, 2023

Last Update Posted : March 28, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Iqvia Pty Ltd

Information provided by (Responsible Party):

Minervax ApS

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	December 14, 2023
Estimated Study Completion Date :	May 16, 2024

To Top